Suppr超能文献

使用持续性非卧床腹膜透析清除β2-微球蛋白

Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis.

作者信息

Sethi D, Murphy C M, Brown E A, Müller B R, Gower P E

机构信息

Department of Medicine, Charing Cross Hospital, London, UK.

出版信息

Nephron. 1989;52(4):352-5. doi: 10.1159/000185676.

Abstract

In the 9 continuous ambulatory peritoneal dialysis (CAPD) patients studied, the mean clearance of beta 2-microglobulin was significantly higher using hypertonic as opposed to isotonic exchanges (1 ml/min and 0.75 ml/min, respectively). Clearance of beta 2-microglobulin correlated with the clearance of albumin. The daily mass transfer of beta 2-microglobulin ranged from 19 to 62 mg. Although all the daily production of beta 2-microglobulin is not eliminated in patients on CAPD their serum beta 2-microglobulin levels would be expected to be lower than in patients on haemodialysis. Long-term prospective studies are needed to determine whether lower serum beta 2-microglobulin levels lead to a lower incidence of dialysis amyloid.

摘要

在所研究的9例持续性非卧床腹膜透析(CAPD)患者中,与等渗交换相比,使用高渗交换时β2-微球蛋白的平均清除率显著更高(分别为1 ml/分钟和0.75 ml/分钟)。β2-微球蛋白的清除率与白蛋白的清除率相关。β2-微球蛋白的每日质量转移量在19至62毫克之间。尽管CAPD患者并未清除所有每日产生的β2-微球蛋白,但预计他们的血清β2-微球蛋白水平会低于血液透析患者。需要进行长期前瞻性研究以确定较低的血清β2-微球蛋白水平是否会导致透析淀粉样变的发生率降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验